Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.32 |
| ▸ | CSF1R | P07333 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.31 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.31 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.31 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1162497 | 0.84 | TRPV4 (0.36) | ALDH1A1HSD17B10TDP1TRPV4 | |
| SCHEMBL29473363 | 0.84 | TRPV4 (0.36) | ALDH1A1HSD17B10TDP1TRPV4 | |
| SCHEMBL28265483 | 0.82 | — | — | |
| SCHEMBL307120 | 0.80 | CYP4F2 (0.37) | ALDH1A1 | |
| SCHEMBL29473362 | 0.77 | ALDH1A1 (0.39) | CTSBALDH1A1HSD17B10TDP1TRPV4 | |
| SCHEMBL1162375 | 0.77 | ALDH1A1 (0.39) | CTSBALDH1A1HSD17B10TDP1TRPV4 | |
| SCHEMBL4446851 | 0.77 | CTSB (0.40) | CTSBALDH1A1HSD17B10TDP1LOXL2 | |
| SCHEMBL16765183 | 0.77 | CSF1R (0.39) | CSF1RMAPK1MAPK9CSNK1DPRKD2 | |
| SCHEMBL3341059 | 0.76 | CYP4F2 (0.33) | ALDH1A1 | |
| SCHEMBL6561657 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8871668-B2 | Immobilized lewis acid catalysts coated with ionic liquids and use thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-10-28 | — | — | US | disclosed |
| EP-1997555-B1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | JAPAN SCIENCE & TECH AGENCY (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-20090318729-A1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-12-24 | — | — | US | disclosed |
| EP-1997555-A1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | Japan Science and Technology Agency (JP) | 2008-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318729-A1 | IMMOBILIZED LEWIS ACID CATALYSTS COATED WITH IONIC LIQUIDS AND USE THEREOF | SELL, LCT, LDHA | CTSB 458/4885ALDH1A1 731/4885HSD17B10 4283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.